Standard
Evaluation and Management of Nonculprit Lesions in STEMI. / Thim, Troels; van der Hoeven, Nina W.; Musto, Carmine; Nijveldt, Robin; Götberg, Matthias; Engstrøm, Thomas; Smits, Pieter C.; Oldroyd, Keith G.; Gershlick, Anthony H.; Escaned, Javier; Baptista, Sergio Bravo; Raposo, Luis; van Royen, Niels; Maeng, Michael.
I:
JACC: Cardiovascular Interventions, Bind 13, Nr. 10, 2020, s. 1145-1154.
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
Thim, T, van der Hoeven, NW, Musto, C, Nijveldt, R, Götberg, M
, Engstrøm, T, Smits, PC, Oldroyd, KG, Gershlick, AH, Escaned, J, Baptista, SB, Raposo, L, van Royen, N & Maeng, M 2020, '
Evaluation and Management of Nonculprit Lesions in STEMI',
JACC: Cardiovascular Interventions, bind 13, nr. 10, s. 1145-1154.
https://doi.org/10.1016/j.jcin.2020.02.030APA
Thim, T., van der Hoeven, N. W., Musto, C., Nijveldt, R., Götberg, M.
, Engstrøm, T., Smits, P. C., Oldroyd, K. G., Gershlick, A. H., Escaned, J., Baptista, S. B., Raposo, L., van Royen, N., & Maeng, M. (2020).
Evaluation and Management of Nonculprit Lesions in STEMI.
JACC: Cardiovascular Interventions,
13(10), 1145-1154.
https://doi.org/10.1016/j.jcin.2020.02.030Vancouver
Thim T, van der Hoeven NW, Musto C, Nijveldt R, Götberg M
, Engstrøm T o.a.
Evaluation and Management of Nonculprit Lesions in STEMI.
JACC: Cardiovascular Interventions. 2020;13(10):1145-1154.
https://doi.org/10.1016/j.jcin.2020.02.030Author
Thim, Troels ; van der Hoeven, Nina W. ; Musto, Carmine ; Nijveldt, Robin ; Götberg, Matthias ; Engstrøm, Thomas ; Smits, Pieter C. ; Oldroyd, Keith G. ; Gershlick, Anthony H. ; Escaned, Javier ; Baptista, Sergio Bravo ; Raposo, Luis ; van Royen, Niels ; Maeng, Michael. / Evaluation and Management of Nonculprit Lesions in STEMI. I: JACC: Cardiovascular Interventions. 2020 ; Bind 13, Nr. 10. s. 1145-1154.
Bibtex
@article{4e87908fcc8147d49c02bfb1105ef01a,
title = "Evaluation and Management of Nonculprit Lesions in STEMI",
abstract = "Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.",
keywords = "CFR, FFR, iFR, nonculprit coronary lesions, STEMI",
author = "Troels Thim and {van der Hoeven}, {Nina W.} and Carmine Musto and Robin Nijveldt and Matthias G{\"o}tberg and Thomas Engstr{\o}m and Smits, {Pieter C.} and Oldroyd, {Keith G.} and Gershlick, {Anthony H.} and Javier Escaned and Baptista, {Sergio Bravo} and Luis Raposo and {van Royen}, Niels and Michael Maeng",
year = "2020",
doi = "10.1016/j.jcin.2020.02.030",
language = "English",
volume = "13",
pages = "1145--1154",
journal = "J A C C: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier",
number = "10",
}
RIS
TY - JOUR
T1 - Evaluation and Management of Nonculprit Lesions in STEMI
AU - Thim, Troels
AU - van der Hoeven, Nina W.
AU - Musto, Carmine
AU - Nijveldt, Robin
AU - Götberg, Matthias
AU - Engstrøm, Thomas
AU - Smits, Pieter C.
AU - Oldroyd, Keith G.
AU - Gershlick, Anthony H.
AU - Escaned, Javier
AU - Baptista, Sergio Bravo
AU - Raposo, Luis
AU - van Royen, Niels
AU - Maeng, Michael
PY - 2020
Y1 - 2020
N2 - Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.
AB - Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.
KW - CFR
KW - FFR
KW - iFR
KW - nonculprit coronary lesions
KW - STEMI
U2 - 10.1016/j.jcin.2020.02.030
DO - 10.1016/j.jcin.2020.02.030
M3 - Review
C2 - 32438985
AN - SCOPUS:85084345472
VL - 13
SP - 1145
EP - 1154
JO - J A C C: Cardiovascular Interventions
JF - J A C C: Cardiovascular Interventions
SN - 1936-8798
IS - 10
ER -
